Ezetimibe treatment in hypercholesterolaemic kidney transplant patients is safe and effective and reduces the decline of renal allograft function: a pilot study | Zendy

T. R. Turk | Zendy; Е. А. Воропаева | Zendy; M. Kohnle | Zendy; Jens Nürnberger | Zendy; Th. Philipp | Zendy; Andreas Kribben | Zendy; Uwe Heemann | Zendy; Oliver Witzke | Zendy

Open Access

Ezetimibe treatment in hypercholesterolaemic kidney transplant patients is safe and effective and reduces the decline of renal allograft function: a pilot study

Author(s) -

T. R. Turk,

Е. А. Воропаева,

M. Kohnle,

Jens Nürnberger,

Th. Philipp,

Andreas Kribben,

Uwe Heemann,

Oliver Witzke

Publication year - 2007

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfm620

Subject(s) - ezetimibe , medicine , renal function , urology , transplantation , kidney disease , creatinine , kidney transplantation , gastroenterology , cholesterol , kidney , prospective cohort study , endocrinology

Ezetimibe has shown efficacy in the therapy of hypercholesterolemia in renal transplant patients. This is the first study investigating the effect of ezetimibe on renal function in kidney transplant recipients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research